Updated just now · Live
Stock analysis, price data, and AI-powered insights for SOPHiA GENETICS SA (SOPH).
SOPHiA GENETICS SA operates in the Health Care sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for SOPH.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). SOPH Stock Intelligence Report. [stoxpulse.com/stocks/soph]
Disclaimer: The information on this page about SOPHiA GENETICS SA (SOPH) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for SOPHiA GENETICS SA.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
SOPHiA GENETICS to Announce Financial Results for ...
9h ago
Mount Sinai Health System and SOPHiA GENETICS Anno...
5d ago
StoxPulse AI results for SOPH: Pulse Score 51.5/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$372.0M
P/E Ratio
—
EPS
—
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
SOPHiA GENETICS Announces Mount Sinai Health System To Implement Its SOPHiA DDM Platform
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8